Summary: Metro News reports on the completion of the MAPS-sponsored clinical trial of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD) in Vancouver, Canada. “With the MDMA, they’d be distressed and crying, but they could talk it through and come to understand it in a way they couldn’t before. The trauma became a more manageable part of their history and they could go forward with their lives,” explains Principal Investigator Ingrid Pacey, Ph.D.
Originally appearing here.